Art

J-GLOBAL ID：201502213322916225   Reference number：15A0943020

Development of new treatments for extranodal NK/T-cell lymphoma in Japan

わが国における節外性NK/T細胞リンパ腫の治療開発

Author (1)： YAMAGUCHI MOTOKO (三重大学大学院医学系研究科 血液・腫瘍内科学)
Material： 臨床血液  (Japanese Journal of Clinical Hematology)
Volume： 56  Issue： 6  Page： 639-644 (J-STAGE)  Publication year： 2015 
JST Material Number： Z0688A  ISSN： 0485-1439  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *T cell lymphoma ,...
Semi thesaurus term： *節外性NK/T細胞リンパ腫 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0943020&from=J-GLOBAL&jstjournalNo=Z0688A") }}

JST classification (3)： Treatment for tumors in general  (GE03031L) ,  Blood cell tumors(=neoplasms)  (GK04000M) ,  Tumors(=neoplasms)of ear,nose,pharynx and larynx  (GQ04000E)

Reference (37)：

• 1) Swerdlow SH, Campo E, Harris NL, et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Fourth Edition, Lyon, IARC Press; 2008.
• 2) The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000; 50: 696-702.
• 3) Yamaguchi M, Kita K, Miwa H, et al. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer. 1995; 76: 2351-2356.
• 4) Drénou B, Lamy T, Amiot L, et al. CD3^-CD56⁺ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood. 1997; 89: 2966-2974.
• 5) Egashira M, Kawamata N, Sugimoto K, et al. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood. 1999; 93: 599-606.

Terms in the title (4)： 節 ,  T細胞リンパ腫 ,  治療 ,  開発